Clinical Trials Logo

Pain, Postoperative clinical trials

View clinical trials related to Pain, Postoperative.

Filter by:

NCT ID: NCT05493085 Recruiting - Clinical trials for Post Operative Pain, Acute

Quadratus Lumborum vs Caudal Epidural Block for Perioperative Analgesia in Pediatric Patients for Upper Abdominal Surgeries

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

Compare between the analgesic effect of the Ultrasound-guided quadratus lumborum block and single Caudal epidural injection in pediatric patients undergoing surgeries with supraumbilical incisions.

NCT ID: NCT05490186 Recruiting - Pain, Postoperative Clinical Trials

Function, Pain, and Alignment Following Knee Replacement for the Treatment of Osteoarthritis

Start date: November 16, 2021
Phase: N/A
Study type: Interventional

There are many factors that can influence patient satisfaction and patient related outcomes following total knee replacement including the surgical alignment of the joint components. Historically, total knee replacements have been performed with an aim aiming to achieve neutral alignment or a mechanical weight axis in the lower extremity . However, only 0.1 % of the population have a pre-surgical anatomical neutral alignment, and therefore the constitutional anatomy of the patient is neglected. There is a growing trend to return patients back their anatomical constitutional alignment after a knee replacement, referred to as Kinematic Alignment using robotics. The aim of this randomized controlled trial is to examine how mechanical alignment and kinematic alignment impacts function, pain, mood and fatigue following TKR for the treatment of osteoarthritis. Outcomes will be measured at 6 week, 6 months, 1 year and 2 years after surgery.

NCT ID: NCT05477303 Recruiting - Pain, Postoperative Clinical Trials

Artificial Intelligence to Evaluate Postoperative Pain Based on Facial Expression

Start date: June 17, 2022
Phase:
Study type: Observational

Patients' subjective complaints about pain intensity are difficult to objectively evaluate, and may lead to inadequate pain management, especially in patients with communication difficulties.

NCT ID: NCT05476575 Recruiting - Pain, Acute Clinical Trials

The Effect of Perioperative Hydrogen Inhalation on Post-operative Pain and Inflammation Cytokines

Start date: October 28, 2021
Phase: N/A
Study type: Interventional

To understand the impact of perioperative hydrogen inhalation on post-operative pain control and serum inflammation markers

NCT ID: NCT05475795 Recruiting - Post Operative Pain Clinical Trials

Postoperative Pain After Pulpectomy of Primary Molars Using Different Obturation Materials

Start date: June 9, 2022
Phase: N/A
Study type: Interventional

Testing postopertive pain after pulpectomy of primary molars with Metapex and Endoflas using modified Wong-Baker scale of pain.

NCT ID: NCT05452967 Recruiting - Clinical trials for Postoperative Pain, Acute

Comparison of Pain Scores by Using Audiovisual Aids.

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This study will be conducted at post anaesthesia care unit of Department of Anesthesiology, Aga Khan University Hospital Karachi. The aim of this study is to compare the post operative analgesia between two groups of post operative paediatric patients, Conventional group, receiving conventional analgesia and the group of patients in which distraction technique will be used. Conventional group will only receive conventional analgesia while the distraction group will receive conventional analgesia as well as distraction technique. Distraction technique that will be used is a non-pharmacological method of pain relief for post-operative paediatric patients in post anesthesia care unit. (games on tablets, listening poems, watching cartoons). Conventional analgesia is the standardise rescue analgesia of intravenous administration of analgesics in post anaesthesia care unit prescribed. The analgesia will include I/V Tramadol 0.5 to 1mg/kg and Paracetamol 10mg/kg). Our primary outcome will be pain scores using Wong-Baker FACES® pain rating scale and parent's satisfaction as secondary outcome.

NCT ID: NCT05452694 Recruiting - Clinical trials for Lumbar Spine Degeneration

OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

Start date: November 1, 2022
Phase:
Study type: Observational

The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone, in adults following lumbar spinal fusion and decompression surgery. Genetic signature and combinatorial pharmacogenetic approaches perform better than single-gene associations. This innovative translational research will for the first time evaluate simultaneously the effects of multiple genes and interactions on oxycodone and methadone's pharmacokinetics and optimal clinical dosing and on its safety and efficacy in the highly vulnerable pediatric population. This research's multigenetic signature findings can be easily extrapolated to adults undergoing surgery or using oxycodone and/or methadone for chronic and cancer pain and in identifying opioid abusers at risk of severe respiratory depression and death. When methadone is given in addition to oxycodone for inpatient pectus excavatum repair and idiopathic scoliosis spinal fusions according to new departmental protocols, methadone pharmacokinetics and pharmacodynamics will also be evaluated.

NCT ID: NCT05445856 Recruiting - Postoperative Pain Clinical Trials

Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

METATONS
Start date: November 28, 2022
Phase: Phase 4
Study type: Interventional

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

NCT ID: NCT05444517 Recruiting - Pain, Postoperative Clinical Trials

Interscalene Block Versus Combined Infraclavicular-Anterior Suprascapular Blocks for Shoulder Surgery

Start date: June 13, 2023
Phase: N/A
Study type: Interventional

Postoperative analgesia after shoulder surgery remains a challenge in patients with preexisting pulmonary pathology, as interscalene brachial plexus block (ISB), the standard nerve block for shoulder surgery, carries a prohibitive risk of hemidiaphragmatic paralysis (HDP). Although several diaphragm-sparing nerve blocks have been proposed, none seems to offer equivalent analgesia to ISB while avoiding HDP altogether. For instance, even costoclavicular blocks, which initially fulfilled both requirements, were subsequently found to result in a non-negligible 5%-incidence of HDP. In this randomized trial, the authors set out to compare ISB and combined infraclavicular block-anterior suprascapular nerve blocks (ICB-ASSNB) for patients undergoing arthroscopic shoulder surgery. The authors hypothesized that ICB-ASSNB would provide equivalent postoperative analgesia to ISB 30 minutes after shoulder surgery and therefore designed the current study as an equivalence trial.

NCT ID: NCT05441150 Recruiting - Post Operative Pain Clinical Trials

Intravenous Ketamine Infusion on Postoperative Analgesia of Living Liver Donors

Start date: June 1, 2022
Phase: Phase 4
Study type: Interventional

Because of the insufficiency of cadaveric organs and increasing need for organs, the interest in living donor liver transplantation have been greatly increased. The relative reduction of the remaining liver after the operation in Living Liver Donors makes it difficult and compelling to choose a very effective and very safe method in the management of postoperative analgesia. Opioids are the main agents used in the postoperative analgesia of Live Liver Donors. Opioids have serious side effects such as respiratory depression, apnea, circulatory collapse, coma, and death. Both short-term and long-term administration of opioids cause acute opioid-induced hyperalgesia. Ketamine, an NMDA receptor antagonist, has been hypothesized to counter opioid tolerance and NMDA receptor-mediated central sensitization. Various studies and systematic reviews have shown that low-dose ketamine has an opioid-sparing effect in all surgical patients. Although low-dose ketamine has been shown to be beneficial overall in relieving pain, it is unclear whether it has an identified benefit in hepatectomy cases. The aim of this clinical trial was to evaluate the effect of low-dose ketamine administration on postoperative analgesia in living donor liver donors undergoing right hepatectomy procedure.